Tag Archives: ESRX

No Comments

CBOE Mid-Day Update 12.22.14

Volatility as an asset class Gilead (GILD) option implied volatility has increased after Express Scripts (ESRX) will offer AbbVie’s (ABBV) just approved hepatitis C regimen Viekira Pak. Gilead is recently down $15.95 to $92.84.  December weekly put option implied volatility is at 55, January is at 41; compared to its 26-week average of 34. Express […]